Uses of Trinicalm Plus 5 mg/2 mg Tablet

Trinicalm Plus 5 mg/2 mg Tablet is used for the treatment or prevention of the following disease(s):

Psychotic Disorders, Anxiety

Side effects of Trinicalm Plus 5 mg/2 mg Tablet

Precautions while taking Trinicalm Plus 5 mg/2 mg Tablet

Dosage of Trinicalm Plus 5 mg/2 mg Tablet

Overdose of Trinicalm Plus 5 mg/2 mg Tablet

Onset of Action of Trinicalm Plus 5 mg/2 mg Tablet

Duration of Action of Trinicalm Plus 5 mg/2 mg Tablet

Precautions & Warnings

Alcohol

Information will be added soon.

Pregnancy

Information will be added soon.

Breastfeeding

Information will be added soon.

Driving

Information will be added soon.

Kidney

Information will be added soon.

Liver

Information will be added soon.

Interactions

Drug :- adsorbent antidiarrheals, aluminum- and magnesium-containing antacids: Possibly inhibited absorption of oral trifluoperazine.

amantadine, anticholinergics, antidyskinetics, antihistamines: Possibly intensified adverse.

anticholinergic effects, increased risk of trifluoperazine-induced hyperpyrexia amphetamines: Decreased stimulant effect.

of amphetamines, decreased antipsychotic effect of trifluoperazine anticonvulsants: Lowered seizure threshold.

antithyroid drugs: Increased risk of agranulocytosis.

apomorphine: Possibly decreased emetic response to apomorphine, additive CNS depression.

appetite suppressants: Decreased effects of appetite suppressants.

astemizole, cisapride, disopyramide, erythromycin, pimozide, probucol, procainamide, quinidine: Prolonged QT interval, increased risk of ventricular tachycardia.

beta blockers: Increased blood levels of both drugs, possibly leading to additive hypotensive.

effect, arrhythmias, irreversible retinopathy, and tardive dyskinesia bromocriptine: Impaired therapeutic effects of bromocriptine.

CNS depressants: Additive CNS depression.

ephedrine, metaraminol: Decreased vasopressor response to ephedrine.

epinephrine: Blocked alpha-adrenergic effects of epinephrine.

extrapyramidal reaction-causing drugs droperidol, haloperidol, metoclopramide, metyrosine, risperidone: Increased severity and frequency of extrapyramidal reactions.

hepatotoxic drugs: Increased risk of hepatotoxicity.

hypotension-producing drugs: Possibly severe hypotension with syncope.

levodopa: Decreased antidyskinetic effect of levodopa.

lithium: Reduced absorption of oral trifluoperazine, possibly encephalopathy and additive extrapyramidal effects.

MAO inhibitors, maprotiline, tricyclic antidepressants: Possibly prolonged and intensified sedative and anticholinergic effects, increased blood level of antidepressants, impaired trifluoperazine metabolism, increased risk of neuroleptic malignant syndrome.

mephentermine: Decreased antipsychotic effect of trifluoperazine and vasopressor effect of mephentermine.

methoxamine, phenylephrine: Decreased vasopressor effect and shortened duration of action of these drugs.

metrizamide: Increased risk of seizures.

opioid analgesics: Increased risk of CNS and respiratory depression, orthostatic hypotension, severe constipation, and urine retention.

ototoxic drugs: Possibly masking of some symptoms of ototoxicity, such as dizziness, tinnitus, and vertigo.

phenytoin: Lowered seizure threshold, inhibited phenytoin metabolism, possibly leading to phenytoin toxicity.

photosensitizing drugs: Possibly additive photosensitivity and intraocular photochemical damage to choroid, lens, or retina.

thiazide diuretics: Possibly hyponatremia and water intoxication.

Activity :- alcohol use: Increased CNS and respiratory depression, increased hypotensive effect.

Kunal is a registered pharmacist with RGUHS with over 4 years experience. He is a medicine content contributor at Health-Shoppe.com.

Dr. Naresh Dang is an MD in Internal Medicine. He has special interest in the field of Diabetes, and has over two decades of professional experience in his chosen field of specialty. Dr. Dang is an expert in the management of Diabetes, Hypertension and Lipids. He also provides consultation for Life Style Management.